What question did this study set out to answer?

Determine the prevalence of hepatitis B and hepatitis C viral markers in individuals with liver diseases, multi-transfused thalassemia patients, and blood donors in Myanmar.

June 1, 2000Open Access

High prevalence of hepatitis C in patients with thalassemia and patients with liver diseases in Myanmar (Burma).

View Full Paper

Ask AI

Bookmark

Authors

SOShigeru OkadaKokushikan University KTKazuhisa TaketaHyogo Medical University TITetsuro IshikawaKashiwa Municipal Hospital

Discussion

Member takes

Implication

Cross-sectional survey reveals high rates of hepatitis C and B in patients with liver diseases and blood transfusion recipients, highlighting an urgent need for blood donor screening.

Key Points

Determine the prevalence of hepatitis B and hepatitis C viral markers in individuals with liver diseases, multi-transfused thalassemia patients, and blood donors in Myanmar.
Conducted a cross-sectional serological survey assessing HBsAg, anti-HBc, and anti-HCV in Myanmar.
Tested 102 patients with liver diseases (including 28 with hepatocellular carcinoma), blood recipients at two hospitals, and 34 voluntary blood donors.
Among 102 liver disease patients, 92% had prior HBV exposure (anti-HBc positive), 35% were HBsAg positive, and 39% tested positive for anti-HCV.
Among 28 hepatocellular carcinoma patients, 46% were HBsAg positive, 21.4% were anti-HCV positive, and 7% tested positive for both markers.
Anti-HCV positivity was 55.5% in transfusion recipients at Yangon General Hospital, 46.7% at Yangon Children's Hospital, and 5.9% (2 of 34) among voluntary blood donors.

Cite This Study

Okada et al. (2000) studied this question.

synapsesocial.com/papers/6ab49c6fb53a6a31a86d8a35 https://doi.org/10.18926/amo/32299

View Full Paper

Ask AI

Bookmark

Implication

Cross-sectional survey reveals high rates of hepatitis C and B in patients with liver diseases and blood transfusion recipients, highlighting an urgent need for blood donor screening.

High prevalence of hepatitis C in patients with thalassemia and patients with liver diseases in Myanmar (Burma).

Discussion

Member takes

Implication

Key Points

Cite This Study

High prevalence of hepatitis C in patients with thalassemia and patients with liver diseases in Myanmar (Burma).

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider